AU2001271839A1 - Human ion channels - Google Patents
Human ion channelsInfo
- Publication number
- AU2001271839A1 AU2001271839A1 AU2001271839A AU7183901A AU2001271839A1 AU 2001271839 A1 AU2001271839 A1 AU 2001271839A1 AU 2001271839 A AU2001271839 A AU 2001271839A AU 7183901 A AU7183901 A AU 7183901A AU 2001271839 A1 AU2001271839 A1 AU 2001271839A1
- Authority
- AU
- Australia
- Prior art keywords
- ion channels
- human ion
- human
- channels
- ion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000004310 Ion Channels Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
Applications Claiming Priority (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21581500P | 2000-07-05 | 2000-07-05 | |
US60/215,815 | 2000-07-05 | ||
US21648200P | 2000-07-06 | 2000-07-06 | |
US21647900P | 2000-07-06 | 2000-07-06 | |
US21648100P | 2000-07-06 | 2000-07-06 | |
US60/216,482 | 2000-07-06 | ||
US60/216,481 | 2000-07-06 | ||
US60/216,479 | 2000-07-06 | ||
US21709600P | 2000-07-10 | 2000-07-10 | |
US60/217,096 | 2000-07-10 | ||
PCT/US2001/021287 WO2002002639A2 (en) | 2000-07-05 | 2001-07-05 | Human ion channels |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001271839A1 true AU2001271839A1 (en) | 2002-01-14 |
Family
ID=27539717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001271839A Abandoned AU2001271839A1 (en) | 2000-07-05 | 2001-07-05 | Human ion channels |
Country Status (4)
Country | Link |
---|---|
US (1) | US7067626B2 (en) |
EP (1) | EP1307551A2 (en) |
AU (1) | AU2001271839A1 (en) |
WO (1) | WO2002002639A2 (en) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6365370B1 (en) | 1999-09-01 | 2002-04-02 | Ortho-Mcneil Pharmaceutical, Inc. | DNA encoding a human subunit 5-HT3-C of the 5-HT3 serotonin receptor |
CA2458915A1 (en) | 2001-08-31 | 2003-03-13 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer |
US8450067B2 (en) * | 2002-05-28 | 2013-05-28 | Omrix Biopharmaceuticals Inc. | Method for obtaining anti-idiotype antibodies |
US20050170360A1 (en) * | 2004-01-30 | 2005-08-04 | Papke Roger L. | Variant neuronal nicotinic alpha-7 receptor and methods of use |
US20060257934A1 (en) * | 2005-04-19 | 2006-11-16 | Svetlana Tertyshnikova | Cell-based assay for the quantitative high throughput screening of gamma-aminobutyric acid-induced halide transport |
US10052497B2 (en) | 2005-07-22 | 2018-08-21 | The Board Of Trustees Of The Leland Stanford Junior University | System for optical stimulation of target cells |
US9274099B2 (en) | 2005-07-22 | 2016-03-01 | The Board Of Trustees Of The Leland Stanford Junior University | Screening test drugs to identify their effects on cell membrane voltage-gated ion channel |
US9238150B2 (en) | 2005-07-22 | 2016-01-19 | The Board Of Trustees Of The Leland Stanford Junior University | Optical tissue interface method and apparatus for stimulating cells |
US8926959B2 (en) | 2005-07-22 | 2015-01-06 | The Board Of Trustees Of The Leland Stanford Junior University | System for optical stimulation of target cells |
US20090093403A1 (en) * | 2007-03-01 | 2009-04-09 | Feng Zhang | Systems, methods and compositions for optical stimulation of target cells |
AU2006284425A1 (en) | 2005-07-22 | 2007-03-01 | The Board Of Trustees Of The Leland Stanford Junior University | Light-activated cation channel and uses thereof |
US8398692B2 (en) | 2007-01-10 | 2013-03-19 | The Board Of Trustees Of The Leland Stanford Junior University | System for optical stimulation of target cells |
US8401609B2 (en) | 2007-02-14 | 2013-03-19 | The Board Of Trustees Of The Leland Stanford Junior University | System, method and applications involving identification of biological circuits such as neurological characteristics |
US10035027B2 (en) | 2007-10-31 | 2018-07-31 | The Board Of Trustees Of The Leland Stanford Junior University | Device and method for ultrasonic neuromodulation via stereotactic frame based technique |
US10434327B2 (en) | 2007-10-31 | 2019-10-08 | The Board Of Trustees Of The Leland Stanford Junior University | Implantable optical stimulators |
EP2385065A1 (en) * | 2007-11-01 | 2011-11-09 | Perseid Therapeutics LLC | Immunosuppressive polypeptides and nucleic acids |
RU2010147661A (en) | 2008-04-23 | 2012-05-27 | Дзе Борд Оф Трастиз Оф Дзе Лелэнд Стэнфорд Джуниор Юниверсити (Us) | SYSTEMS, METHODS AND COMPOSITIONS FOR THE OPTICAL STIMULATION OF TARGET CELLS |
ES2532235T3 (en) | 2008-05-29 | 2015-03-25 | The Board Of Trustees Of The Leland Stanford Junior University | Cell line, system and procedure for the optical control of secondary messengers |
EP2294082A4 (en) * | 2008-06-13 | 2011-07-13 | Ct For Addiction And Mental Health | Compositions and methods for modulating nicotinic/nmda receptor function |
MX2010014100A (en) | 2008-06-17 | 2011-03-04 | Univ Leland Stanford Junior | Methods, systems and devices for optical stimulation of target cells using an optical transmission element. |
MY162929A (en) * | 2008-06-17 | 2017-07-31 | Univ Leland Stanford Junior | Apparatus and methods for controlling cellular development |
US9101759B2 (en) | 2008-07-08 | 2015-08-11 | The Board Of Trustees Of The Leland Stanford Junior University | Materials and approaches for optical stimulation of the peripheral nervous system |
US8435762B2 (en) * | 2008-10-09 | 2013-05-07 | Howard Hughes Medical Institute | Chimeric ligand-gated ion channels and methods of use thereof |
NZ602416A (en) | 2008-11-14 | 2014-08-29 | Univ Leland Stanford Junior | Optically-based stimulation of target cells and modifications thereto |
SG10201505162QA (en) | 2010-03-17 | 2015-08-28 | Univ Leland Stanford Junior | Light-sensitive ion-passing molecules |
WO2012061679A2 (en) | 2010-11-05 | 2012-05-10 | The Board Of Trustees Of The Leland Stanford Junior University | Light-activated chimeric opsins and methods of using the same |
EP2635346B1 (en) | 2010-11-05 | 2017-03-29 | The Board of Trustees of the Leland Stanford Junior University | Optogenetic control of reward-related behaviors |
AU2011323231B2 (en) | 2010-11-05 | 2016-01-07 | The Board Of Trustees Of The Leland Stanford Junior University | Upconversion of light for use in optogenetic methods |
US10086012B2 (en) | 2010-11-05 | 2018-10-02 | The Board Of Trustees Of The Leland Stanford Junior University | Control and characterization of memory function |
US10568307B2 (en) | 2010-11-05 | 2020-02-25 | The Board Of Trustees Of The Leland Stanford Junior University | Stabilized step function opsin proteins and methods of using the same |
CA3056186A1 (en) | 2010-11-05 | 2012-05-10 | Board Of Trustees Of The Leland Stanford Junior University | Optically-controlled cns dysfunction |
US8696722B2 (en) | 2010-11-22 | 2014-04-15 | The Board Of Trustees Of The Leland Stanford Junior University | Optogenetic magnetic resonance imaging |
AU2012352429B2 (en) | 2011-12-16 | 2018-07-19 | The Board Of Trustees Of The Leland Stanford Junior University | Opsin polypeptides and methods of use thereof |
EP3205374B1 (en) | 2012-02-21 | 2019-03-27 | The Board of Trustees of The Leland Stanford Junior University | Compositions for treating neurogenic disorders of the pelvic floor |
US9636380B2 (en) | 2013-03-15 | 2017-05-02 | The Board Of Trustees Of The Leland Stanford Junior University | Optogenetic control of inputs to the ventral tegmental area |
WO2014144409A1 (en) | 2013-03-15 | 2014-09-18 | The Board Of Trustees Of The Leland Stanford Junior University | Optogenetic control of behavioral state |
CA2908864A1 (en) | 2013-04-29 | 2014-11-06 | The Board Of Trustees Of The Leland Stanford Junior University | Devices, systems and methods for optogenetic modulation of action potentials in target cells |
US10307609B2 (en) | 2013-08-14 | 2019-06-04 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for controlling pain |
US10568516B2 (en) | 2015-06-22 | 2020-02-25 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and devices for imaging and/or optogenetic control of light-responsive neurons |
US11294165B2 (en) | 2017-03-30 | 2022-04-05 | The Board Of Trustees Of The Leland Stanford Junior University | Modular, electro-optical device for increasing the imaging field of view using time-sequential capture |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
US4879236A (en) | 1984-05-16 | 1989-11-07 | The Texas A&M University System | Method for producing a recombinant baculovirus expression vector |
US5242794A (en) | 1984-12-13 | 1993-09-07 | Applied Biosystems, Inc. | Detection of specific sequences in nucleic acids |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US5202231A (en) | 1987-04-01 | 1993-04-13 | Drmanac Radoje T | Method of sequencing of genomes by hybridization of oligonucleotide probes |
WO1990005183A1 (en) | 1988-10-31 | 1990-05-17 | Immunex Corporation | Interleukin-4 receptors |
JP3501286B2 (en) | 1989-12-22 | 2004-03-02 | アプライド リサーチ システムズ,エーアールエス ホールディング ナームロゼ ベノートスハップ | Methods for altering the expression characteristics of endogenous genes in certain cell lines or microorganisms |
AU651596B2 (en) | 1990-06-05 | 1994-07-28 | Immunex Corporation | Type II interleukin-1 receptors |
EP0539573A4 (en) | 1991-05-15 | 1993-12-29 | Cell Genesys, Inc. | Genomic modifications with homologous dna targeting |
ATE408012T1 (en) | 1991-12-02 | 2008-09-15 | Medical Res Council | PRODUCTION OF AUTOANTIBODIES ON PHAGE SURFACES BASED ON ANTIBODIES SEGMENT LIBRARIES |
TW402639B (en) | 1992-12-03 | 2000-08-21 | Transkaryotic Therapies Inc | Protein production and protein delivery |
US5585277A (en) | 1993-06-21 | 1996-12-17 | Scriptgen Pharmaceuticals, Inc. | Screening method for identifying ligands for target proteins |
AU1662595A (en) | 1994-01-28 | 1995-08-15 | Herbert Altmann | Method of determining the activity of a regulatory factor, and use of the method |
GB9501567D0 (en) | 1995-01-26 | 1995-03-15 | Pharmacia Spa | Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors |
GB9518220D0 (en) | 1995-09-06 | 1995-11-08 | Medical Res Council | Checkpoint gene |
US6017757A (en) | 1997-02-20 | 2000-01-25 | Mississippi State University | Isolated viable nematode intestinal cells |
US6703485B2 (en) | 1997-12-23 | 2004-03-09 | The Trustees Of Columbia University In The City Of New York | Brain and heart cyclic nucleotide gated ion channel compounds and uses thereof |
US6365370B1 (en) * | 1999-09-01 | 2002-04-02 | Ortho-Mcneil Pharmaceutical, Inc. | DNA encoding a human subunit 5-HT3-C of the 5-HT3 serotonin receptor |
CA2393538A1 (en) | 1999-12-14 | 2001-06-21 | Pharmacia & Upjohn Company | Human ion channels |
WO2001068849A2 (en) | 2000-03-10 | 2001-09-20 | Pharmacia & Upjohn Company | Human ion channels |
JP2002223762A (en) * | 2001-01-30 | 2002-08-13 | Takeda Chem Ind Ltd | New protein and dna encoding the same |
-
2001
- 2001-07-05 WO PCT/US2001/021287 patent/WO2002002639A2/en active Application Filing
- 2001-07-05 EP EP01950888A patent/EP1307551A2/en not_active Withdrawn
- 2001-07-05 AU AU2001271839A patent/AU2001271839A1/en not_active Abandoned
- 2001-07-05 US US09/899,495 patent/US7067626B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20030088060A1 (en) | 2003-05-08 |
US7067626B2 (en) | 2006-06-27 |
WO2002002639A3 (en) | 2003-03-13 |
EP1307551A2 (en) | 2003-05-07 |
WO2002002639A2 (en) | 2002-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001271839A1 (en) | Human ion channels | |
AUPR179500A0 (en) | Ion source | |
AU2001273239A1 (en) | Transporters and ion channels | |
AU2001241963A1 (en) | Improved medical procedure | |
AU2001280981A1 (en) | Transporters and ion channels | |
AU2001259702A1 (en) | Tissue regrafting | |
AU2001268525A1 (en) | Human kinases | |
AU2001238488A1 (en) | Human kinases | |
AU2001288612A1 (en) | Human kinases | |
AU2001277959A1 (en) | Human kinases | |
AU2002241569A1 (en) | Transporters and ion channels | |
AU2001291011A1 (en) | Transporters and ion channels | |
AU2002239190A1 (en) | Ion sorces | |
AU2001265002A1 (en) | Transporters and ion channels | |
AU2002227925A1 (en) | Human beta-defensin-3 | |
AU2001239860A1 (en) | Transporters and ion channels | |
AU2002256215A1 (en) | Transporters and ion channels | |
AU2001249906A1 (en) | Human transporters and ion channels | |
AU2001264957A1 (en) | Human ion channels | |
AU2001255573A1 (en) | Human kinases | |
AU2001257570A1 (en) | Human ion channels | |
AU2002332573A1 (en) | Transporters and ion channels | |
AU2001247460A1 (en) | 18615 and 48003, human ion channels and uses therefor | |
AU2001247330A1 (en) | Human ion channels | |
AU2001257378A1 (en) | 23949 and 32391, human ion channels and uses thereof |